Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II randomized double-blind trial of an inactivated quadrivalent enterovirus vaccine in healthy adults and children
CTR20244977Phase 2Active
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jan 2025
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Tetravalent inactivated enterovirus vaccine (2 arms), sponsored by Sinovac Biotech Ltd. Started Jan 2025; status: active.
02
Drugs
Tetravalent inactivated enterovirus vaccine
Beyond the preview
Go deeper on CTR20244977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244977.